Clinical Trials Browser

Phase 4 × INDUSTRY × luprolide acetate gel depot × Clear all

NCT03035032 2024-11-26

A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

Phase 4 Completed

107 enrolled 25 charts

Prostatic Neoplasms

NCT05304169 2022-03-31

PRIZE

Phase 4 Completed

Prostatic Neoplasms

NCT01933022 2017-03-09

EFFECT

Phase 4 Terminated

Prostatic Neoplasms

NCT01511874 2015-09-23

Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

Phase 4 Completed

Prostatic Neoplasms